Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/1997
07/02/1997EP0781278A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
07/02/1997EP0781277A1 Neurokinin antagonists
07/02/1997EP0781273A1 4-(4-methanesulfonamidophenyl)butylamine derivatives with antiarrhythmic activity
07/02/1997EP0781268A1 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system
07/02/1997EP0781139A1 Intracellular delivery of chemical agents to a specific cell type
07/02/1997EP0781138A2 Lipid analogs for treating viral infections
07/02/1997EP0781137A1 Novel compositions containing phosphoglycero ethers, and use thereof for treating neurodegenerative diseases
07/02/1997EP0781136A1 Compounds and methods for the treatment of cancer
07/02/1997EP0781135A1 Codeine containing formulations
07/02/1997EP0781134A1 Scopolamine plaster
07/02/1997EP0781133A1 Fibrinogen receptor antagonists
07/02/1997EP0781132A1 Methods of inhibiting ulcerative mucositis
07/02/1997EP0781131A1 Inducers of gamma globin gene expression and screening assays therefor
07/02/1997EP0781130A1 Method for sleep induction
07/02/1997EP0781129A1 Pharmaceutical preparation containing metformin and a process for producing it
07/02/1997EP0781128A2 Clotrimazole metabolites in the treatment of sickle cell disease
07/02/1997EP0781127A1 Anaesthetic analgesic gas mixtures containing enflurane or isoflurane in combination with sevoflurane or desflurane
07/02/1997EP0781126A2 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system
07/02/1997EP0781124A1 Active agent transport systems
07/02/1997EP0781092A1 Method of sensitizing tumor cells with adenovirus e1a
07/02/1997EP0730588B1 Isoxazoline compounds as antiinflammatory agents
07/02/1997EP0703911B1 Secondary amines as antidiabetic and antiobesity agents
07/02/1997EP0632806B1 Aminocyclohexylamides for antiarrhythmic and anaesthetic uses
07/02/1997EP0544713B1 Oligonucleotides for modulating the effects of cytomegalovirus infections
07/02/1997EP0527757B1 Composition and methods for treatment of acne vulgaris and retardation of ageing
07/02/1997EP0522082B1 Multi-functional pharmaceutical compounds and methods of use
07/02/1997CN1153517A Quinoxalindione derivs., their preparation and their use in drugs
07/02/1997CN1153513A N,N'-bis (quinolin-4-yl)-diamine derivs, their preparation and their use as antimalarials
07/02/1997CN1153510A Amide derivs. and their therapeutic use
07/02/1997CN1153476A Use of oligonucleotide phosphorothioate for depleting complement and for reducing blood pressure
07/02/1997CN1153475A Carbamazepine medicament with retarded active substance release
07/02/1997CN1153474A Stable oil-in-water emulsions incorporating taxine (taxol) and method of making same
07/02/1997CN1153473A Use of droloxifene for treatment of cardiovascular diseases
07/02/1997CN1153179A Method for separation and purification of lentinan
07/02/1997CN1153176A Stable crystalline tetrahydrofolic acid salts
07/02/1997CN1153172A Azole derivatives, their use, production and usage
07/02/1997CN1153171A Anticancer preparation
07/02/1997CN1153170A Substd. Benzene dicarboxylic biguanides, process for preparing same and their use as medicines and diagnosis agent, and medicines contg. same
07/02/1997CN1153169A Substd. benzene dicarboxylic biguanide amides, their preparing method, their use as medicines and diagnosis agent, and medicines contg. same
07/02/1997CN1153168A Elemene hydroxyls derivs. and their use as anticancer drugs
07/02/1997CN1153158A Elemene-metal complex and use as anticancer drugs
07/02/1997CN1153040A Athlete's foot ointment
07/02/1997CN1153039A Specific
07/02/1997CN1035333C Method for prodn. of salinomycin and its crystalline sodium salt
07/01/1997US5644058 Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines
07/01/1997US5644055 Cyclization of indole or quinoline compound, enzyme inhibitors, treatment of cardiovasacular disorders
07/01/1997US5644054 Process for preparing diltiazem
07/01/1997US5644053 Beta-lactamase inhibitors or bactericide antibiotics
07/01/1997US5644051 Intermediates for the preparation of carbacephems
07/01/1997US5644050 Method for manufacturing lactulose anhydride
07/01/1997US5643967 Animal growth regulators of beta-phenethanolamines for feed efficiency
07/01/1997US5643966 Antitumor agents
07/01/1997US5643965 Treatment of dopamine associated nervous system disorders
07/01/1997US5643964 Natural amino acid derivatives as metalloproteinase inhibitors
07/01/1997US5643963 Aging resistance of skin by reducing wrinkles
07/01/1997US5643962 Skin disorders
07/01/1997US5643961 Method of using malic acid for treating wrinkles
07/01/1997US5643960 Method of delaying onset of alzheimer's disease symptoms
07/01/1997US5643959 Method for treating patients with precancerous lesions by administering substituted sulfonyl indenyl acetic and propionic acids and esters thereof
07/01/1997US5643957 Compounds and compositions for delivering active agents
07/01/1997US5643954 Stress resistance or nootropic effect using glycine and methyl cellulose in tablet form
07/01/1997US5643953 Method of using 3-phenyllactic acid for treating wrinkles
07/01/1997US5643952 Skin disorders
07/01/1997US5643950 Triphenylalkyl antimicrobial agents
07/01/1997US5643949 Cosmetic composition for hair and skin disorders in humans
07/01/1997US5643947 ω-amino-α-phenylalkanonitrile derivatives
07/01/1997US5643946 Compounds useful for treating allergic and inflammatory diseases
07/01/1997US5643944 Administering arginine, sodium nitroprusside, nitroglycerine and idosorbide mono or dinitrate mixture to stimulate ovulation
07/01/1997US5643943 Systemic administration of esters and amides of antioxidants which may be used as antioxidant prodrug therapy for oxidative and inflammatory pathogenesis
07/01/1997US5643942 Methods, composition and solutions for treating alopecia
07/01/1997US5643940 Dioxapyrrolomycin as an antiparasitic agent and compositions useful therefor
07/01/1997US5643939 Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation
07/01/1997US5643938 Pyrazolopyridine compounds for the treatment of anemia
07/01/1997US5643937 Anti-seborrhoeic formulation
07/01/1997US5643936 Treatment of angiogenic conditions and anticarcinogenic agents
07/01/1997US5643935 Method of combatting infectious diseases using dicationic bis-benzimidazoles
07/01/1997US5643934 Treating serotonin-related disorders
07/01/1997US5643932 Superoxide radical inhibitor
07/01/1997US5643931 Bisoxadiazolidine derivative
07/01/1997US5643930 6-heterocyclic-4-amino-1,3,4,5,-tetrahydrobenz [cd]indoles
07/01/1997US5643929 Treatment of picornaviral or rhinovirus and chemical intermediates
07/01/1997US5643928 Human body weight management
07/01/1997US5643927 4-p-fluorobenzoyl-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis and schizophrenia
07/01/1997US5643925 Benzene derivatives having NGF production-promoting activity
07/01/1997US5643924 Retroviral protease inhibitors
07/01/1997US5643923 Treatment of anxiety, cognition activators, senility or alzheimer's
07/01/1997US5643922 Indole cyclohexyl platelet activating factor antagonists
07/01/1997US5643921 Cardiopulmonary bypass and organ transplant using a potassium channel activator
07/01/1997US5643917 4-aminomethyl-1-azaadamantane derived benzamides
07/01/1997US5643916 Tetrahydro-beta-carbolines
07/01/1997US5643915 Antiinflammatory agents
07/01/1997US5643913 Pharmaceutical compositions of 5-substituted uracil compounds
07/01/1997US5643911 Cerebrovascular disease
07/01/1997US5643910 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz[CD]indoles
07/01/1997US5643909 10,11-Methanodibenzosuberane derivatives
07/01/1997US5643908 Collagenase inhibitor
07/01/1997US5643907 Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of CNS disorders
07/01/1997US5643906 Lowering intraocular pressure for treatment of glaucoma
07/01/1997US5643905 Pharmaceutical formulation for the treatment of nicotine dependence
07/01/1997US5643902 Amoxycillin, clavulanic acid